Skip to content
buyWeak cluster of 410b5-1 plan

Caroline Young bought $398 of CPIX

director at CUMBERLAND PHARMACEUTICALS INC. 121 shares at an average of $3.29, traded Aug 1, 2025, filed Sep 12, 2025.

Conviction score
23
Value
$398
121 shares
Holdings after
32,942
+0% from before
From 52-week low
+232%
low $0.82, close $2.73
From 52-week high
-48%
high $5.25, as of Aug 1, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $398 at market
    0
  • Relative to holdings
    Under 1% of holdings (0.4%)
    -5
  • Price context
    48% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    3 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -15

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CPIXOct 9, 2026 · close 7.03
Since filing Sep 12, 2025: +163.5%SPY +20.0% · excess +143.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-041989, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 1, 2025POpen-market purchase
Common Stock10b5-1
+6$3.44$2132,827Sep 12, 2025
Aug 4, 2025POpen-market purchase
Common Stock10b5-1
+6$4.01$2432,833Sep 12, 2025
Aug 5, 2025POpen-market purchase
Common Stock10b5-1
+6$3.92$2432,839Sep 12, 2025
Aug 6, 2025POpen-market purchase
Common Stock10b5-1
+6$3.34$2032,845Sep 12, 2025
Aug 7, 2025POpen-market purchase
Common Stock10b5-1
+6$3.14$1932,851Sep 12, 2025
Aug 8, 2025POpen-market purchase
Common Stock10b5-1
+6$3.39$2032,857Sep 12, 2025
Aug 11, 2025POpen-market purchase
Common Stock10b5-1
+6$2.87$1732,863Sep 12, 2025
Aug 12, 2025POpen-market purchase
Common Stock10b5-1
+6$2.91$1732,869Sep 12, 2025
Aug 13, 2025POpen-market purchase
Common Stock10b5-1
+6$2.94$1832,875Sep 12, 2025
Aug 14, 2025POpen-market purchase
Common Stock10b5-1
+6$2.84$1732,881Sep 12, 2025
Aug 15, 2025POpen-market purchase
Common Stock10b5-1
+6$3.02$1832,887Sep 12, 2025
Aug 18, 2025POpen-market purchase
Common Stock10b5-1
+6$3.11$1932,893Sep 12, 2025
Aug 19, 2025POpen-market purchase
Common Stock10b5-1
+6$3.23$1932,899Sep 12, 2025
Aug 20, 2025POpen-market purchase
Common Stock10b5-1
+1$3.15$332,900Sep 12, 2025
Aug 21, 2025POpen-market purchase
Common Stock10b5-1
+6$3.25$2032,906Sep 12, 2025
Aug 22, 2025POpen-market purchase
Common Stock10b5-1
+6$3.31$2032,912Sep 12, 2025
Aug 25, 2025POpen-market purchase
Common Stock10b5-1
+6$3.32$2032,918Sep 12, 2025
Aug 26, 2025POpen-market purchase
Common Stock10b5-1
+6$3.39$2032,924Sep 12, 2025
Aug 27, 2025POpen-market purchase
Common Stock10b5-1
+6$3.44$2132,930Sep 12, 2025
Aug 28, 2025POpen-market purchase
Common Stock10b5-1
+6$3.47$2132,936Sep 12, 2025
Aug 29, 2025POpen-market purchase
Common Stock10b5-1
+6$3.45$2132,942Sep 12, 2025

Related signals

Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,516
1,372 shares
+0%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$862
262 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$862
262 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$5,872
1,712 shares
+1%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$1,166
340 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$1,166
340 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$578
168 shares
+1%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,513
935 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$807
168 shares
+0%
29Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$807
168 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Caroline Young bought $398 of CPIX | InsiderTell